From page 3 of the annual report:
"The Company holds an exclusive 25 year license to use Ablation, a proven technology that we anticipate will improve the efficiency of the sandstone-hosted uranium mining process. The license agreement was entered into on March 17, 2015 and expires on March 16, 2040. There are no remaining license fee obligations and there are no future royalties due under the agreement. The Company has an exclusive right to the Ablation, including the right to sub-license the technology to other third parties."
https://www.sec.gov/Archives/edgar/data/1621906/000121390017003160/f10k2016_westernuranium.htm#a_015
Exclusive?
From the 2015 Technology License Agreement with Ablation Technologies:
"2.3 Reservation of Rights Not Granted. AT (Ablation Technologies, LLC), with respect to the AT Technology, reserves all rights not specifically granted herein to BRMA (Black Range Minerals Ablation Holdings Inc.), including the right to use the AT Technology and to enter into licenses and other agreements with Third Parties for the use and application of the AT Technology and Improvements thereto for recovery of Uranium Minerals and Minerals."
Makes one wonder what Mr. Glasier is telling investors, exclusive or non-exclusive ablation license?
- Forums
- ASX - By Stock
- BLR
- Annual report
Annual report, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online